Teva Likes Biosimilar Licensing Deals As It Cuts Full-Year Sales Guidance

Recent Deal Brought In Bioeq’s Lucentis Biosimilar In Europe

 
• By Dean Rudge
Business Growth
Licensing deals 'will not be huge blockbusters' • Source: Alamy

More from Earnings

More from Business